SAN FRANCISCO -- A new type of COVID-19 therapy is showing promise as a new tool to hijack the virus and slow down variants. It's a new weapon that could be added to the arsenal against COVID-19.

Pregnant patients are less likely to receive antiviral treatment for COVID than for influenza despite guideline ...

Although the general population now has at least some immunity against COVID-19, the consequences of severe disease are frequently overlooked for certain patient populations, such as those with ...

A new program from eMed and the NIH offers free tests and treatments, and you don't even need to leave your home.

The virus that causes COVID-19 might be becoming resistant to antiviral treatments, new research has warned. But should we be concerned? The antiviral drugs nirmatrelvir and remdesivir are recommended ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Antiviral therapy reduced incidence of long COVID-19 ...

CHICAGO -- Pfizer has begun a Phase 2 and 3 clinical trial of its COVID-19 antiviral treatment, Paxlovid, in children ages 6 to 17, the company said Wednesday in a news release. The study will ...

NEW YORK -- When Laura Martin tested positive for COVID-19 last month during an extended stay in California, she was prescribed Paxlovid, the highly touted antiviral drug created by Pfizer. Just one ...

Pfizer announced Wednesday it has begun phases 2 and 3 of its pediatric clinical trial for Paxlovid, its COVID-19 antiviral treatment. The study will look into how effective and safe the treatment is ...

An in vitro study finds that nitric oxide may suppress SARS-CoV-2, the virus that causes COVID-19. The researchers suggest that inhaled nitric oxide may be an effective treatment for the disease. All ...

As mask mandates are lifted, and mitigation measures are increasingly dropped across the nation, a stark reality continues to hinder the nation's return to a pre-pandemic sense of normality. Hundreds ...